Homepage | Annals of the Rheumatic Diseases
2025年1月17日 · The homepage of Annals of the Rheumatic Diseases, a leading rheumatology journal published by BMJ and EULAR.
Home | Annals of the Rheumatic Diseases
2024年10月11日 · Annals of the Rheumatic Diseases (ARD) is an international peer-reviewed journal committed to promoting the highest standards of scientific exchange and education.
Authors - Annals of the Rheumatic Diseases
BMJ is committed to ensuring that all good quality research is published. Our article transfer service helps authors find the best journal for their research while providing an easy and smooth publication process. If authors agree to transfer their manuscript, all versions, supplementary files and peer reviewer comments are automatically transferred; without …
EULAR recommendations for the management of rheumatoid …
Objectives To provide an update of the EULAR rheumatoid arthritis (RA) management recommendations addressing the most recent developments in the field. Methods An international task force was formed and solicited three systematic literature research activities on safety and efficacy of disease-modifying antirheumatic drugs (DMARDs) and glucocorticoids (GCs). The new evidence was discussed in ...
Online First - Annals of the Rheumatic Diseases
Efficacy, safety and tolerability of GSK3858279, an anti-CCL17 monoclonal antibody and analgesic, in healthy volunteers and patients with knee osteoarthritis pain: a phase I, randomised, double-blind, placebo-controlled, proof-of-mechanism and proof-of-concept study
About - Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases (ARD) is an international peer review journal committed to promoting the highest standards of scientific exchange and education. It covers all aspects of rheumatology, which includes the spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders.
Therapeutic interception in individuals at risk of rheumatoid …
2024年9月23日 · Multiple clinical trials for rheumatoid arthritis (RA) prevention have been completed. Here, we set out to report on the lessons learnt from these studies. Researchers who conducted RA prevention trials shared the background, rationale, approach and outcomes and evaluated the lessons learnt to inform the next generation of RA prevention trials. Individuals at risk of RA can be identified ...
Safety of synthetic and biological DMARDs: a systematic literature ...
Objectives To perform a systematic literature review (SLR) concerning the safety of synthetic (s) and biological (b) disease-modifying anti rheumatic dugs (DMARDs) to inform the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis (RA). Methods An SLR of observational studies comparing safety outcomes of any DMARD with another intervention for the management of RA.
Top cited articles - Annals of the Rheumatic Diseases
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update 2023 ACR/EULAR antiphospholipid syndrome classification criteria Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and ...
Efficacy of synthetic and biological DMARDs: a systematic …
2022年1月14日 · Objectives To update the evidence on efficacy of DMARDs (disease-modifying antirheumatic drugs) and inform the taskforce of the 2022 update of the European Alliance of Associations for Rheumatology (EULAR) recommendations for management of rheumatoid arthritis (RA). Methods This systematic literature review (SLR) investigated the efficacy of conventional synthetic (cs), biological (b ...